Latest News
aTyr Pharma, Inc.
- Atyr Pharma Announces Research Collaboration With Montefiore Einstein
- ATyr Pharma stock drops nearly 3% after intensifying oversold momentum signals
- aTyr Pharma shows promising anti-fibrotic effec...
- What's behind aTyr Pharma's latest 3.0% stock surge?
- aTyr Pharma Reaches FDA Protocol Agreement for Efzofitimod Phase 3 Trial
- aTyr Pharma reaches FDA alignment on phase 3 sarcoidosis trial
- aTyr Pharma Jumps 5% After FDA Signs Off on Phase 3 Trial Design for Lung Disease Drug
- aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
- Positive FDA Alignment Boosts ATyr Pharma's Rare Lung Disease
- Why is aTyr Pharma stock rallying today?
- aTyr Pharma says FDA aligned on 372‑patient sarcoidosis trial
- Why is aTyr Pharma stock surging today?
Headlines from the last 30 days, linking to the original publishers. See all market news →